Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Age-specific propofol dose optimization for neonatal endotracheal intubation
NL-OMON45172Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of propofol in None, sponsored by Erasmus MC. Primary endpoints: Appropriate propofol dose in 8 age groups, Adequate sedation and 2 more. Started Aug 2014; status: active, not recruiting.
02
Drugs
propofol
Beyond the preview
Go deeper on NL-OMON45172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45172.